Crossmark

If the evidence is there, why are GLP-1 receptor agonists not on-label for hip and knee osteoarthritis in overweight patients?

Published Online: 2025-09-23

Published Print: 2025-07

Authors

Ursini, Francesco https://orcid.org/0000-0001-8194-8642
Ciaffi, Jacopo https://orcid.org/0000-0002-9446-7351
Caporali, Roberto https://orcid.org/0000-0001-9300-6169
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct06191848 at ClinicalTrials.gov

Documents that mention this clinical trial

If the evidence is there, why are GLP-1 receptor agonists not on-label for hip and knee osteoarthritis in overweight patients?
https://doi.org/10.1136/rmdopen-2025-006025
License Information

License valid from 2025-09-24

Document is current